Construction of Fosmid-based SARS-CoV-2 replicons for antiviral drug screening and replication analyses in biosafety level 2 facilities
S. Takazawa, T. Kotaki, S. Nakamura, C. Utsubo, M. Kameoka
This paper constructs SARS-CoV-2 replicons for antiviral drug screening in BSL-2 facilities and validates their replication and functionality.
bioRxiv · Feb 15, 2023Microbiology